K El-Baz et al., 2023 - Google Patents
Potential production of omega fatty acids from Scenedesmus obliquus microalgae: Evaluation of acute and chronic toxicityK El-Baz et al., 2023
View PDF- Document ID
- 6122947660435883657
- Author
- K El-Baz F
- Salah D
- Abougharam G
- Ali S
- Aly H
- Publication year
- Publication venue
- Egyptian Journal of Chemistry
External Links
Snippet
Background: Omega-3 fatty acids (O3FA) as dietary supplements for medical use improve health. Methods: Acute and chronic toxicity were done using male and female rats. Results of acute toxicity showed no behavioral alterations, toxicity, or mortality in treated animals at a …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having 2 or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6705599B2 (en) | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making them and their use | |
JP5491697B2 (en) | Composition comprising high level omega-3 and low level saturated fatty acids | |
JP5546087B2 (en) | Oral treatment or prevention agent for skin diseases | |
Sayeda et al. | Potential production of omega fatty acids from microalgae | |
Choopani et al. | Spirulina: a source of gamma-linoleic acid and its applications | |
Dąbrowski et al. | Update on food sources and biological activity of odd-chain, branched and cyclic fatty acids––A review | |
Robertson et al. | Algae-derived polyunsaturated fatty acids: implications for human health | |
Calviello et al. | Dietary omega-3 polyunsaturated fatty acids and cancer | |
US20220233488A1 (en) | Very long chain fatty acids for treatment and alleviation of diseases | |
Mimouni et al. | Marine microalgae used as food supplements and their implication in preventing cardiovascular diseases | |
Yang et al. | Technological readiness of commercial microalgae species for foods | |
Qiu et al. | Biosafety evaluation of Nannochloropsis oculata and Schizochytrium sp. oils as novel human milk fat substitutes | |
K El-Baz et al. | Potential production of omega fatty acids from Scenedesmus obliquus microalgae: Evaluation of acute and chronic toxicity | |
El-Baz et al. | http://ejchem. journals. ekb. eg | |
Jang et al. | Immune-modulation effect of Halocynthia aurantium tunic lipid on RAW264. 7 cells | |
WO2011067666A1 (en) | Processes to generate compositions of enriched fatty acids | |
Singh et al. | Biotechnological application of algae in pharmaceuticals industries with special reference to omega-3 fatty acid and human health | |
Sahin | Effect of oil extract from microalgae (Schizochytrium sp.) on the viability and apoptosis of human osteosarcoma cells | |
JP6203320B2 (en) | Oral treatment or prevention agent for skin diseases | |
Ferreri | Omega 3 fatty acids and bioactive foods: from biotechnology to health promotion | |
JP2012082226A (en) | Oral agent for treatment or prevention of cutaneous disease | |
EP2079824B1 (en) | Modified alkoxyglycerols | |
WO2023145785A1 (en) | Thrombosis preventive agent | |
JP6462790B2 (en) | Oral treatment or prevention agent for skin diseases | |
Singh et al. | 3 BiotechnologicalofAlgaein Pharmaceuticals Application Industries with Special Reference to Omega-3 Fatty Acid and Human Health |